Insufficient scRNA-seq data for expression of PLPP6 at single-cell level.
Insufficient scRNA-seq data for expression of PLPP6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1169.80 | 328 / 328 | 100% | 12.64 | 178 / 178 |
prostate | 100% | 1072.89 | 245 / 245 | 100% | 57.65 | 502 / 502 |
breast | 100% | 577.87 | 459 / 459 | 100% | 21.08 | 1116 / 1118 |
bladder | 100% | 645.81 | 21 / 21 | 100% | 16.32 | 503 / 504 |
stomach | 100% | 930.72 | 358 / 359 | 100% | 15.39 | 286 / 286 |
esophagus | 100% | 571.36 | 1438 / 1445 | 100% | 11.13 | 183 / 183 |
liver | 100% | 978.73 | 226 / 226 | 100% | 17.43 | 404 / 406 |
thymus | 100% | 603.34 | 653 / 653 | 99% | 15.32 | 601 / 605 |
intestine | 100% | 757.08 | 964 / 966 | 99% | 18.19 | 524 / 527 |
uterus | 100% | 477.53 | 170 / 170 | 99% | 14.04 | 455 / 459 |
lung | 98% | 415.55 | 568 / 578 | 100% | 13.32 | 1152 / 1155 |
adrenal gland | 100% | 811.48 | 258 / 258 | 98% | 12.20 | 225 / 230 |
kidney | 100% | 481.64 | 89 / 89 | 98% | 8.67 | 881 / 901 |
brain | 98% | 559.22 | 2587 / 2642 | 99% | 10.56 | 696 / 705 |
ovary | 97% | 359.87 | 175 / 180 | 99% | 11.86 | 425 / 430 |
skin | 100% | 882.69 | 1809 / 1809 | 94% | 9.57 | 444 / 472 |
adipose | 100% | 428.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.98 | 29 / 29 |
spleen | 100% | 753.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.28 | 1 / 1 |
blood vessel | 99% | 396.30 | 1321 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 6.50 | 68 / 80 |
heart | 83% | 195.60 | 717 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 64% | 288.59 | 593 / 929 | 0% | 0 | 0 / 0 |
muscle | 58% | 112.87 | 462 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018342 | Biological process | protein prenylation |
GO_1902565 | Biological process | positive regulation of neutrophil activation |
GO_0045087 | Biological process | innate immune response |
GO_0046839 | Biological process | phospholipid dephosphorylation |
GO_0006720 | Biological process | isoprenoid metabolic process |
GO_0045339 | Biological process | farnesyl diphosphate catabolic process |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_1902247 | Biological process | geranylgeranyl diphosphate catabolic process |
GO_0033383 | Biological process | geranyl diphosphate metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005637 | Cellular component | nuclear inner membrane |
GO_0031965 | Cellular component | nuclear membrane |
GO_0008195 | Molecular function | phosphatidate phosphatase activity |
GO_0106405 | Molecular function | isoprenoid diphosphate phosphatase activity |
GO_0016787 | Molecular function | hydrolase activity |
GO_0052642 | Molecular function | lysophosphatidic acid phosphatase activity |
GO_0042577 | Molecular function | lipid phosphatase activity |
GO_0042392 | Molecular function | sphingosine-1-phosphate phosphatase activity |
GO_0016829 | Molecular function | lyase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PLPP6 |
Protein name | Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 (EC 3.1.3.-) (EC 3.6.1.-) (EC 3.6.1.68) (Lipid phosphatase-related protein-B) (LPRP-B) (PA-PSP) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (PPAP2 domain-containing protein 2) (Phospholipid phosphatase 6) (Presqualene diphosphate phosphatase) (Type 1 polyisoprenoid diphosphate phosphatase) |
Synonyms | PPAPDC2 PDP1 |
Description | FUNCTION: Magnesium-independent polyisoprenoid diphosphatase that catalyzes the sequential dephosphorylation of presqualene, farnesyl, geranyl and geranylgeranyl diphosphates . Functions in the innate immune response through the dephosphorylation of presqualene diphosphate which acts as a potent inhibitor of the signaling pathways contributing to polymorphonuclear neutrophils activation . May regulate the biosynthesis of cholesterol and related sterols by dephosphorylating presqualene and farnesyl diphosphate, two key intermediates in this biosynthetic pathway . May also play a role in protein prenylation by acting on farnesyl diphosphate and its derivative geranylgeranyl diphosphate, two precursors for the addition of isoprenoid anchors to membrane proteins . Has a lower activity towards phosphatidic acid (PA), but through phosphatidic acid dephosphorylation may participate in the biosynthesis of phospholipids and triacylglycerols . May also act on ceramide-1-P, lysophosphatidic acid (LPA) and sphing-4-enine 1-phosphate/sphingosine-1-phosphate . . |
Accessions | Q8IY26 ENST00000381883.5 |